Reading time is 1 mins
.
.
ANTALYA YACHT REVENUE EXCEEDED $ 1.4 BILLION
Antalya, one of the most important super luxury yacht centers in the world, is in the Free Zone; 30 yachts were launched in 2021, and $ 125 million in revenue was provided. The total production of the yacht sector in the region reached 510 super luxury yachts and a revenue of 1 billion 403 million dollars.
Antalya Free Zone ranks first in Turkey, which is the 3rd in the world after Italy and the Netherlands in the production of super luxury yachts and boats. The basement and followed by salt and Antalya, which opened last year, 560 ton travel lift, 300-foot dock and 2 thousand tons – lift ship accommodating yachts of 90 meters and the most important investments in Turkey in the eastern Mediterranean yacht became a center for manufacturing. With these investments, there is also a significant increase in orders in the Turkish yacht sector.
Stating that about 50 companies operate in the yacht sector in the region, Antalya Free Zone, General Manager announced that 30 new super luxury yachts were completed last year and $ 125 million in revenue was provided, noted that the total production of the yacht sector, which started in the 2000s and is developing rapidly in the region, has reached 510 super luxury yachts to date, and the total revenue has increased to $ 1 billion 403 million. “The total length of 510 yachts was 9 thousand 750 meters,” said.
.
$49 MILLION IN MAINTENANCE AND REPAIR REVENUE
Noting that yachts produced in the region are sent to countries such as the USA, the Netherlands, Norway, Oman, Senegal, South Africa, YACHT Director said that in recent years, the field of maintenance and repair has also begun to be in serious demand. To date, a total of 142 boats have been serviced and repaired, 127 of them have been completed and delivered, and $49 million in revenue has been provided, said.
.
.
.
.
Turkey's world-renowned organ transplant specialist. Dr. Demirbaş has 104 international publications and 102 national publications.
Physician's Resume:
Born on August 7, 1963 in Çorum, Prof. Dr. Alper Demirbaş has been continuing his work as the President of MedicalPark Antalya Hospital Organ Transplantation Center since 2008.
Prof. who performed the first tissue incompatible kidney transplant in Turkey, the first blood type incompatible kidney transplant, the first kidney-pancreas transplant program and the first cadaveric donor and live donor liver transplant in Antalya. Dr. As of August 2016, Alper Demirbaş has performed 4900 kidney transplants, 500 liver transplants and 95 pancreas transplants.
In addition to being the chairman of 6 national congresses, he has also been an invited speaker at 12 international and 65 national scientific congresses. Dr. Alper Demirbaş was married and the father of 1 girl and 1 boy.
Awards:
Eczacibasi Medical Award of 2002, Akdeniz University Service Award of 2005, Izder Medical Man of the Year Award of 2006, BÖHAK Medical Man of the Year Award of 2007, Sabah Mediterranean Newspaper Scientist of the Year Award of 2007, ANTIKAD Scientist of the Year Award of 2009, Social Ethics Association Award of 2010, Işık University Medical Man of the Year Award of 2015, VTV Antalya's Brand Value Award of 2015.
Certificates:
Doctor of Medicine Degree Hacettepe University Faculty of Medicine Ankara, General Surgeon Ministry of Health Turkey EKFMG (0-477-343-8), University of Miami School of Medicine Member of Multiple Organ Transplant, ASTS Multiorgan Transplant Scholarship. Lecturer at Kyoto University. Lecturer at University of Essen, Research assistant at the University of Cambridge .
Professional Members:
American Society of Transplant Surgeons, American Transplantation Society Nominated, Middle East and Southern Africa Council Transplantation Society 2007, International Liver Transplantation Association, Turkish Transplantation Association, Turkish Society of Surgery, Turkish Hepatobiliary Surgery Association.
Disclaimer:
Our website contents consist of articles approved by our Web and Medical Editorial Board with the contributions of our physicians. Our contents are prepared only for informational purposes for public benefit. Be sure to consult your doctor for diagnosis and treatment.